First Time Loading...

High Tide Inc
XTSX:HITI

Watchlist Manager
High Tide Inc Logo
High Tide Inc
XTSX:HITI
Watchlist
Price: 2.75 CAD -1.43% Market Closed
Updated: Apr 29, 2024

Relative Value

The Relative Value of one HITI stock under the Base Case scenario is 9.66 CAD. Compared to the current market price of 2.75 CAD, High Tide Inc is Undervalued by 72%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HITI Relative Value
Base Case
9.66 CAD
Undervaluation 72%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
47
vs Industry
87
Median 3Y
0.4
Median 5Y
0.4
Industry
2.4
Forward
0.4
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-6.7
Industry
22.9
Forward
-94.7
vs History
30
vs Industry
38
Median 3Y
8.2
Median 5Y
6.7
Industry
17.1
vs History
7
vs Industry
12
Median 3Y
-10.8
Median 5Y
-12.1
Industry
23.2
vs History
52
vs Industry
47
Median 3Y
1.2
Median 5Y
1.9
Industry
2.1
vs History
57
vs Industry
88
Median 3Y
0.5
Median 5Y
0.4
Industry
2.6
Forward
0.4
vs History
52
vs Industry
78
Median 3Y
1.7
Median 5Y
1.4
Industry
5.1
vs History
52
vs Industry
42
Median 3Y
21.3
Median 5Y
7.5
Industry
13.6
Forward
6.1
vs History
4
vs Industry
1
Median 3Y
-10.5
Median 5Y
-14.2
Industry
17
Forward
45.8
vs History
36
vs Industry
38
Median 3Y
9.1
Median 5Y
8
Industry
15.8
vs History
22
vs Industry
27
Median 3Y
-14.9
Median 5Y
-20.6
Industry
17.6
vs History
34
vs Industry
53
Median 3Y
1
Median 5Y
1
Industry
1.9

Multiples Across Competitors

HITI Competitors Multiples
High Tide Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
High Tide Inc
XTSX:HITI
216m CAD 0.4 -5.4 7 179.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
696.4B USD 20.4 132.9 60.1 68.9
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17 47.2 34.6 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
351.8B USD 4.3 8.7 11.6 15.3
US
Merck & Co Inc
NYSE:MRK
332.2B USD 5.5 910 45.2 88.2
UK
AstraZeneca PLC
LSE:AZN
185.8B GBP 5.1 39 140.5 225.4
CH
Novartis AG
SIX:NOVN
182.9B CHF 4.3 13.5 9.9 16.3
CH
Roche Holding AG
SIX:ROG
176.2B CHF 3 15.3 8.7 10.4
P/E Multiple
Earnings Growth
CA
High Tide Inc
XTSX:HITI
Average P/E: 1 362.5
Negative Multiple: -5.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
132.9
346%
DK
Novo Nordisk A/S
CSE:NOVO B
47.2
84%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
9 733.7
-24%
US
Johnson & Johnson
NYSE:JNJ
8.7
-20%
US
Merck & Co Inc
NYSE:MRK
910
7 454%
UK
AstraZeneca PLC
LSE:AZN
39
168%
CH
Novartis AG
SIX:NOVN
13.5
15%
CH
Roche Holding AG
SIX:ROG
15.3
26%

See Also

Discover More